Neuromuscular Disorders
Volume 18, Issue 4 , Pages 342-348 , April 2008

Mdx respiratory impairment following fibrosis of the diaphragm

  • Masatoshi Ishizaki

      Affiliations

    • Department of Neurology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
    • These authors contributed equally to this work.
    • ,
  • Tomohiro Suga

      Affiliations

    • Department of Neurology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
    • These authors contributed equally to this work.
    • ,
  • En Kimura

      Affiliations

    • Department of Neurology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 96 373 5893; fax: +81 96 373 5895.
    • ,
  • Tetsuya Shiota

      Affiliations

    • GalPharma Co., Ltd., Kagawa, Japan
    • ,
  • Ryoko Kawano

      Affiliations

    • Department of Neurology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
    • ,
  • Yuji Uchida

      Affiliations

    • Laboratory of Pharmacology, Division of Life Science, Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan
    • ,
  • Katsuhisa Uchino

      Affiliations

    • Department of Neurology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
    • ,
  • Satoshi Yamashita

      Affiliations

    • Department of Neurology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
    • ,
  • Yasushi Maeda

      Affiliations

    • Department of Neurology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan
    • ,
  • Makoto Uchino

      Affiliations

    • Department of Neurology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan

Received 1 October 2007 ,Revised 1 February 2008 ,Accepted 5 February 2008.

References 

  1. Hoffman EP, Brown RH, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987;51:919–928
  2. Zubrzycka-Gaarn EE, Bulman DE, Karpati G, et al. The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature. 1988;333:466–469
  3. Koenig M, Monaco AP, Kunkel LM. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell. 1988;53:219–228
  4. Bushby KM, Hill A, Steele JG. Failure of early diagnosis in symptomatic Duchenne muscular dystrophy. Lancet. 1999;353:557–558
  5. Eagle M, Baudouin SV, Chandler C, et al. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul. Disord. 2002;12:926–929
  6. Blake DJ, Weir A, Newey SE, et al. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev. 2002;82:291–329
  7. Ishiura S, Nonaka I, Fujita T, et al. Effect of cycloheximide administration on bupivacaine-induced acute muscle degradation. J. Biochem. (Tokyo). 1983;94:1631–1636
  8. Chamberlain JS, Metzger J, Reyes M, et al. Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. FASEB J. 2007;21:2195–2204
  9. McArdle A, Edwards RH, Jackson MJ. How does dystrophin deficiency lead to muscle degeneration?--evidence from the mdx mouse. Neuromuscul. Disord. 1995;5:445–456
  10. Stedman HH, Sweeney HL, Shrager JB, et al. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature. 1991;352:536–539
  11. Gosselin LE, Williams JE. Pentoxifylline fails to attenuate fibrosis in dystrophic (mdx) diaphragm muscle. Muscle Nerve. 2006;33:820–823
  12. Bogdanovich S, Krag TO, Barton ER, et al. Functional improvement of dystrophic muscle by myostatin blockade. Nature. 2002;420:418–421
  13. Wagner KR, McPherron AC, Winik N, et al. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann. Neurol. 2002;52:832–836
  14. Sampaolesi M, Blot S, D’Antona G, et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature. 2006;444:574–579
  15. Blankinship MJ, Gregorevic P, Allen JM, et al. Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. Mol. Ther. 2004;10:671–678
  16. Gregorevic P, Blankinship MJ, Allen JM, et al. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat. Med. 2004;10:828–834
  17. Harper SQ, Hauser MA, DelloRusso C, et al. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat. Med. 2002;8:253–261
  18. Yoshimura M, Sakamoto M, Ikemoto M, et al. AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype. Mol. Ther. 2004;10:821–828
  19. Li S, Kimura E, Fall BM, et al. Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin. Gene Ther. 2005;12:1099–1108
  20. Matecki S, Dudley RW, Divangahi M, et al. Therapeutic gene transfer to dystrophic diaphragm by an adenoviral vector deleted of all viral genes. Am. J. Physiol. Lung Cell Mol. Physiol. 2004;287:L569–L576
  21. Dudley RW, Lu Y, Gilbert R, et al. Sustained improvement of muscle function one year after full-length dystrophin gene transfer into mdx mice by a gutted helper-dependent adenoviral vector. Hum. Gene Ther. 2004;15:145–156
  22. Lefort J, Singer M, Leduc D, et al. Systemic administration of endotoxin induces bronchopulmonary hyperreactivity dissociated from TNF-alpha formation and neutrophil sequestration into the murine lungs. J. Immunol. 1998;161:474–480
  23. Gosselin LE, Barkley JE, Spencer MJ, et al. Ventilatory dysfunction in mdx mice: impact of tumor necrosis factor-alpha deletion. Muscle Nerve. 2003;28:336–343
  24. Schnyder-Candrian S, Quesniaux VF, Di Padova F, et al. Dual effects of p38 MAPK on TNF-dependent bronchoconstriction and TNF-independent neutrophil recruitment in lipopolysaccharide-induced acute respiratory distress syndrome. J. Immunol. 2005;175:262–269
  25. Quinlan JG, Hahn HS, Wong BL, et al. Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings. Neuromuscul. Disord. 2004;14:491–496
  26. Uchida Y, Maeda Y, Kimura E, et al. Effective repetitive dystrophin gene transfer into skeletal muscle of adult mdx mice using a helper-dependent adenovirus vector expressing the coxsackievirus and adenovirus receptor (CAR) and dystrophin. J. Gene Med. 2005;7:1010–1022
  27. Matecki S, Rivier F, Hugon G, et al. The effect of respiratory muscle training with CO2 breathing on cellular adaptation of mdx mouse diaphragm. Neuromuscul. Disord. 2005;15:427–436
  28. Dupont-Versteegden EE. Exercise and clenbuterol as strategies to decrease the progression of muscular dystrophy in mdx mice. J. Appl. Physiol. 1996;80:734–741

PII: S0960-8966(08)00030-8

doi: 10.1016/j.nmd.2008.02.002

Neuromuscular Disorders
Volume 18, Issue 4 , Pages 342-348 , April 2008

Article Tools

* Image Usage & Resolution